Middle East Tech Today: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Middle East Tech Today.

Press releases published on July 7, 2026

Certara Accelerates Drug Discovery and Development with NVIDIA BioNeMo Agent Toolkit
Forterra Reveals It Rapidly Manufactured and Deployed Autonomous Systems to Ukraine at Scale in Russo-Ukrainian War
Kahuna Labs Introduces AI-Powered Escalation Prevention to Help Enterprises Stop Escalations Before They Happen
GoldHaven Commences Targeted IP Survey Following High-Grade Copper Discoveries at Three Guardsmen
Rezolve Ai Introduces Auditable AI, Completing the Foundation for Trusted Enterprise AI Commerce
Enlivex Announces 1-for-15 Reverse Stock Split Effective July 9, 2026
BIO-key Regains Compliance with Nasdaq Listing Rules; Nasdaq Trading Resumes on Wednesday, July 8th
Clearmind Reports Successful Formulation Feasibility Study Supporting Potential New Additional Route of Administration Development for MEAI
Vivani Medical Enters into Agreement with Novo Nordisk to Evaluate NPM-139, a Miniature, Ultra Long-Acting Semaglutide Implant for Chronic Weight Management
Acumen Pharmaceuticals to Present Data on Enhanced Brain Delivery™ (EBD™) Technology and Early Alzheimer’s Disease Insights at the Alzheimer’s Association International Conference (AAIC®) 2026
Cornerstone First Mortgage Switches to nCino's Mortgage Point of Sale to Support Its Next Phase of Growth
BriaCell Engages Consulting and Branding Firms to Support Commercial and Market Access Evaluation of Bria-IMT™
ZenaTech’s ZenaDrone Advances Defense Drone Portfolio with Initial IQ Sphere Prototype for Autonomous GPS-Denied Inspections, Surveillance and Reconnaissance Missions
Cytokinetics Announces Three Late-Breaking Science Abstracts at the European Society of Cardiology (ESC) Congress 2026
Global Collaborations Continue to Validate Dyadic’s C1 Platform and Expands Commercial Potential
AI Takes Center Stage at Blockchain Futurist Conference 2026
Alterity Therapeutics Receives FDA End-of-Phase 2 Meeting Minutes Confirming Registrational Pathway for ATH434 in Multiple System Atrophy
Teva to Advance Its Anti-IL-15 Antibody, Designed for Quarterly Dosing, Into Phase 2b Development in Vitiligo, Following Encouraging Phase 1b Results
HMNC Brain Health Announces Publication of Ketabon (KET01) Clinical Trial Results in JAMA Network Open
AC Immune to Showcase Neurodegenerative Disease Pipeline with Three Presentations at AAIC® 2026

Share this page:

Advanced Search Options

Search for:

Search scope:

Type:

Search in:

Date range:

The last

Sort by:

Sign up for:

Middle East Tech Today

The daily local news briefing you can trust. Every day. Subscribe now.

By signing up, you agree to our Terms & Conditions.